DNM1 and COVID-19: Our study supports the conclusion that targeting dynamin and cholesterol with small molecule inhibitors, Dyngo4a and mβCD, can offer a new approach for the prevention of SARS-CoV-2 infection in mink and complement COVID-19 vaccines.